New β-lactam-β-lactamase inhibitor combinations in clinical development von Shlaes, David M.

Volltext

The Economic Conundrum for Antibacterial Drugs von Shlaes, David M

Volltext

Can Europe Pull It Together? von Shlaes, David M

Volltext

The FDA Reboot of Antibiotic Development von SHLAES, David M, SAHM, Dan, OPIELA, Carol, SPELLBERG, Brad

Volltext

Innovation, Nontraditional Antibacterial Drugs, and Clinical Utility von Shlaes, David M

Volltext

Antibacterial Drugs: The Last Frontier von Shlaes, David M.

Volltext

Eight more ways to deal with antibiotic resistance von Metz, Matthew, Shlaes, David M

Volltext

Personal View of the Antibiotic Value Proposition von Shlaes, David M.

Volltext

Overcoming the challenges to developing new antibiotics von Shlaes, David M, Spellberg, Brad

Volltext

Antibiotics-From There to Where?: How the antibiotic miracle is threatened by resistance and a broken market and what we can do about it von Shlaes, David M, Bradford, Patricia A

Volltext

Reply to "Simple solutions reflect misunderstanding of animal antibiotic use" von Metz, Matthew, Shlaes, David M

Volltext

Research and Development of Antibiotics: The Next Battleground von Shlaes, David M

Volltext

Fix the antibiotics pipeline von Cooper, Matthew A., Shlaes, David

Volltext

Mechanism of Action of the Mannopeptimycins, a Novel Class of Glycopeptide Antibiotics Active against Vancomycin-Resistant Gram-Positive Bacteria von RUZIN, Alexey, SINGH, Guy, BRADFORD, Patricia A, SEVERIN, Anatoly, YOUJUN YANG, DUSHIN, Russell G, SUTHERLAND, Alan G, MINNICK, Albert, GREENSTEIN, Michael, MAY, Michael K, SHLAES, David M

Volltext

3,5-Dioxopyrazolidines, Novel Inhibitors of UDP-N- Acetylenolpyruvylglucosamine Reductase (MurB) with Activity against Gram-Positive Bacteria von YOUJUN YANG, SEVERIN, Anatoly, SHLAES, David M, RASMUSSEN, Beth A, FAILLI, Amedeo A, SHUMSKY, Jay S, KUTTERER, Kristina M. K, GILBERT, Adam, MANSOUR, Tarek S, CHOPRA, Rajiv, KRISHNAMURTHY, Girija, SINGH, Guy, HU, William, KEENEY, David, SVENSON, Kristine, PETERSEN, Peter J, LABTHAVIKUL, Pornpen

Volltext

The abandonment of antibacterials: why and wherefore? von Shlaes, David M

Volltext

5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of β-lactamases von Venkatesan, Aranapakam M., Agarwal, Atul, Abe, Takao, Ushirogochi, Hideki, Ado, Mihira, Tsuyoshi, Takasaki, Dos Santos, Osvaldo, Li, Zhong, Francisco, Gerry, Lin, Yang I., Petersen, Peter J., Yang, Youjun, Weiss, William J., Shlaes, David M., Mansour, Tarek S.

Volltext

In Memoriam: John P. Quinn, MD von Perez, Federico, Arias, Cesar A., Bush, Karen, Drusano, George L., Lolans, Karen, Munoz-Price, L. Silvia, Nicolau, David P., Queenan, Anne Marie, Rice, Louis B., Segreti, John, Shlaes, David M., Weinstein, Robert A., Bonomo, Robert A.

Volltext

Telithromycin and the FDA: implications for the future von Shlaes, David M, Moellering, Robert C

Volltext

Simulating Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model von Campos, Marcelino, Capilla, Rafael, Naya, Fernando, Futami, Ricardo, Coque, Teresa, Moya, Andrés, Fernandez-Lanza, Val, Cantón, Rafael, Sempere, José M, Llorens, Carlos, Baquero, Fernando

Volltext